Hormone Therapy Breast Cancer Screening Pilot
Part of Cancer, Skin clinical trials.
This pilot study tests a new way to screen for breast cancer in people who have taken hormone therapy (like estrogen, progesterone, or testosterone). It aims to include both men and women between 40 and 75, and younger people (30-39) with a family history of breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Men ages 40-75 who have taken estrogen or progesterone therapy for at least 9 months
- Women ages 40-75 who have taken testosterone therapy (even if had cosmetic breast surgery, but not full removal)
- Anyone ages 30-39 with a close family member who had breast cancer (parent, sibling, grandparent, aunt/uncle)
- Must be able to understand and sign a consent form in English
- Women who have had a full mastectomy or are postmenopausal on estrogen/progesterone cannot take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing how well a short course of hormone-blocking pills (endocrine therapy) works before surgery in women with early-stage hormone receptor-positive HER2-negative breast cancer. The goal is to understand what makes some cancers resistant to these treatments.
This Phase 2 study tests an individualized vaccine made from your tumor information to help your immune system fight hormone-positive breast cancer. You may be able to participate if you meet specific hormone-receptor, health, and treatment-timing requirements.
This study looks at how genetic tests like Oncotype DX or Mammaprint are used to guide treatment decisions for people with early-stage, hormone receptor-positive (HR+) and HER2-negative breast cancer. It aims to help doctors choose between hormone therapy alone or chemotherapy plus hormone therapy.
This study tests tools to help people talk with employers and medical staff about breast cancer treatment while working. It aims to improve how treatment and job needs are discussed so patients can get support.
This study looks at the potential harms and benefits of hormone (endocrine) therapy in people age 70 and older with early-stage, hormone-receptor–positive breast cancer. It may help doctors choose which hormone treatment approach is safest and most helpful for older patients.
This study looks at people who are being screened and just diagnosed with breast cancer and haven’t started treatment yet. It may help researchers understand how to better manage care from the start of treatment.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.